Appointment of CCO

Summary by AI BETAClose X

4basebio PLC has promoted Christine Wolosin to Chief Commercial Officer, tasking her with leading global commercial strategy and business development to scale its synthetic DNA platform for cell and gene therapy, mRNA, and vaccine markets. This move follows the recent appointment of Dr. Amy Walker as CEO and is supported by the promotions of James Vang to VP, Business Development, and Jennifer Gelman to VP, Marketing, all aimed at accelerating the company's commercial growth and market penetration as demand for alternatives to plasmid DNA increases.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings